ANALYSISApril 13, 2026
Should medical malpractice awards be capped?
A wave of state legislation in 2025–2026 is reshaping medical malpractice damage caps across the U.S., with Florida reinstating a $750,000 non-economic damage cap, Colorado, Montana, and New Mexico adjusting their limits, and courts in Ohio and Colorado issuing significant rulings on cap constitutionality. The debate is intensifying as so-called 'nuclear verdicts' — defined as $10 million or more — are increasing in frequency and size, with the average of the top 50 medical malpractice verdicts reaching $56 million in 2024, up from $32 million in 2022. The AMA's 2025 Policy Research Perspectives report found that nearly half of all medical liability insurance rate filings showed premium increases in 2024, the highest level since 2005.
When a botched surgery leaves someone permanently disabled, who decides what that suffering is worth — a jury of peers, or a legislature that set the ceiling years before the injury happened? And if the cap is too low, are we quietly telling the worst-harmed patients that their losses are legally invisible?
Not familiar with this story? Get context →
Caps actually reduce insurance premiums
C
The empirical record across decades is consistent: cap states have lower malpractice premiums. California's MICRA held the market stable through multiple national insurance crises, and the peer-reviewed finding that a $250,000 cap reduces average payments by 20% tells us precisely what threshold does the work. This is not an industry talking point — it's a finding replicated across dozens of states and multiple methodologies.
L
The Ohio court in Paganini looked at actual state insurance data and found no measurable effect of caps on rates — and you acknowledge that finding 'cannot simply be waved away.' If your case rests on cross-sectional comparisons while the one study using real insurer filings finds nothing, that's a problem you can't resolve by pointing at California.
C
A single state's insurance market — with its specific cap level, enforcement history, and insurer structure — cannot overturn a finding replicated across dozens of states. Paganini may be identifying a local anomaly, and notably Ohio's cap may have been set too high to do any actuarial work, which is exactly what the $500,000 findings predict.
L
Then you've conceded the real debate: if only low caps work, the caps being enacted — Florida at $750,000, Colorado approaching $875,000 — are calibrated to limit liability, not stabilize markets. You're defending a principle while the actual legislation does something else.
Caps drive physician supply increases
C
Texas enacted its $250,000 cap in 2003 and licensed more than 10,000 additional physicians within five years, with the steepest gains in obstetrics and emergency medicine — exactly the high-risk specialties that leave when tail risk becomes uninsurable. This is supply-and-demand operating exactly as predicted: cap the tail risk, make insurance purchasable, doctors practice.
L
Texas also had explosive population growth, a booming economy, and favorable licensing conditions in that same window. Attributing 10,000 new physicians to the cap requires ruling out every other variable — and you haven't done that. Correlation across a decade of Texas growth isn't a controlled experiment.
C
The steepest gains were in obstetrics and emergency medicine — precisely the specialties most exposed to malpractice tail risk, not the ones you'd expect to respond to general population growth or licensing conditions. That specificity is hard to explain away.
L
It's less hard to explain when those specialties were also the ones receiving targeted federal funding and recruitment incentives in that period — but even granting some physician supply effect, the question is whether that benefit justifies capping a child with cerebral palsy at $250,000. You haven't shown the tradeoff favors the system over that child.
Nuclear verdicts reflect jury manipulation not harm
C
The top 50 malpractice verdicts averaged $56 million in 2024 — up 75% from $32 million just two years earlier. The nationwide average payment was $420,000, meaning the median case settles reasonably while the upper tail detonates. What you're seeing in that tail isn't accurate pricing of catastrophic harm — it's venue shopping and reptile-theory jury strategies that untether awards from any compensatory logic.
L
The Colorado Supreme Court unanimously affirmed a $40 million birth-injury verdict in Banner Health v. Gresser — not a runaway jury, a unanimous appellate court reviewing the evidence. You're calling the top verdicts irrational, but the courts reviewing them keep disagreeing with you. Maybe $40 million for a lifetime of cerebral palsy care isn't a lottery win; maybe it's arithmetic.
C
Banner Health is one case with one fact pattern — the uniform appellate courts don't see the pre-trial venue selection, the reptile framing, or the cases that settled under verdict threat. Unanimous affirmance tells you the verdict survived review; it doesn't tell you the liability environment isn't being gamed upstream.
L
You're asking us to cap recoveries based on litigation dynamics that happen before trial, for which you have no clean data, while the actual verdicts keep getting affirmed by courts that do have the evidence. That's a thin foundation for telling the most seriously injured patients their suffering has a ceiling.
Fixed caps erode justice over time
C
The principled cap is one properly designed and indexed to inflation. California's MICRA held stable for nearly five decades, and yes — that's a real problem with how it was implemented, not with the cap mechanism itself. The answer to erosion is indexing, not abolition.
L
California's cap sat at $250,000 from 1975 to 2022 — 47 years, no adjustment. In real purchasing power, that's roughly $60,000 in 1975 dollars by the time it was finally raised. You say 'index it,' but the legislature set a number, called it justice, and let inflation quietly make it meaningless for nearly half a century. That's not a design flaw — that's what legislatures do.
C
The fact that California's legislature failed to index doesn't mean indexing is impossible — it means California's implementation was deficient. Every policy can be poorly implemented; that's an argument for better design, not for leaving the upper tail unregulated.
L
The burden of proof runs the other way: you're proposing to limit what the most catastrophically injured patients can recover, so show me the state that enacted a cap, indexed it faithfully, and kept it calibrated to real harm over decades. Until you can point to that, 'better design' is a theoretical fix for a demonstrated failure pattern.
Who actually bears the cost of caps
C
A healthcare system with fewer physicians delivering fewer procedures to rural and underserved communities harms vulnerable populations more comprehensively and permanently than any individual verdict can vindicate them. The rural patient who loses her obstetrician suffers a real, population-level harm — even if she never knows the liability environment caused it.
L
You've just made the case for invisible harms over visible ones. The child with cerebral palsy capped at $250,000 knows exactly what the system took from her. The rural patient who 'never knows what she lost' — by your own framing — is a statistical abstraction you're deploying to limit a specific, identifiable person's recovery. That asymmetry should trouble you.
C
Statistical lives are still lives. Public health policy routinely trades identifiable individual losses against diffuse population benefits — that's how vaccination policy, speed limits, and drug approval work. Calling the rural patient an 'abstraction' doesn't make her less harmed when she can't access an obstetrician.
L
The difference is that vaccination and speed limits don't achieve their population benefits by taking compensation away from people the system already failed. We're not asking the cerebral palsy child to accept a lower recovery so we can fund rural clinics — we're asking her to subsidize insurer pricing stability. Those are not the same moral transaction.
Conservative's hardest question
The Ohio court's finding in Paganini — that caps showed no measurable effect on insurance rates — is difficult to dismiss because it draws on actual state insurance data rather than cross-sectional comparisons, and the peer-reviewed finding that $500,000 caps have no statistically significant effect on payments raises a genuine question about whether caps set at $750,000 or higher accomplish anything beyond limiting recovery for the most catastrophically injured plaintiffs.
Liberal's hardest question
The most difficult evidence to dismiss is that nearly all rigorous empirical studies since 1990 find that malpractice premiums are lower in cap states — a consistent finding across decades and methodologies. If that correlation is causal, then opposing caps means accepting some degree of real cost to physician supply and insurance affordability, and the argument shifts from 'caps don't work' to 'the tradeoff favors injured patients over system stability,' which is a harder case to make to a rural community that lost its only obstetrician.
Both sides agree: Both sides accept that a $250,000 cap meaningfully reduces average malpractice payments while a $500,000 cap does not, making the specific level of a cap — not its existence — the operative policy variable.
The real conflict: A factual and causal conflict: conservatives argue cross-state research consistently shows caps reduce premiums and physician supply improves, while liberals argue state-level insurance data — as in Paganini — shows no measurable rate effect, and that these findings cannot be reconciled by calling one side a local anomaly.
What nobody has answered: If a $500,000 cap has no statistically significant effect on malpractice payments but current caps are being set at $750,000 to $875,000, who precisely benefits from those caps — and is there any public record that answers that question honestly?
Sources
- AMA 2025 Policy Research Perspectives report on medical liability insurance rate filings
- Colorado Supreme Court, Banner Health v. Gresser (October 2025)
- Ohio Eighth District Court of Appeals, Paganini v. Cataract Eye Center of Cleveland (January 2025)
- Florida 2025 legislation reinstating $750,000 non-economic damage cap (effective January 1, 2025)
- Colorado House Bill 24-1472 on noneconomic damage cap increases
- Montana HB 195 (2025) revising noneconomic damage limits
- New Mexico HB 99 signed March 6, 2026
- California MICRA cap schedule (2022 amendment phased increases through 2033)
- Peer-reviewed research on $250,000 and $500,000 cap effects on average malpractice payments
- AMA 2025 Interim Meeting House of Delegates directives on model tort reform legislation